Rising prostate-specific antigen values during neoadjuvant androgen deprivation therapy: The importance of monitoring
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation
Reference32 articles.
1. Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate;Lawton;Int J Radiat Oncol Biol Phys,2001
2. Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer;Zagars;Urology,2001
3. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study);Bolla;Lancet,2002
4. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer;Kataja;Ann Oncol,2003
5. 6-month androgen suppression plus radiation therapy vs. radiation therapy alone for patients with clinically localized prostate cancer;D’Amico;JAMA,2004
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prognostic value of biochemical response to neoadjuvant androgen deprivation before external beam radiotherapy for prostate cancer: A systematic review of the literature;Cancer Treatment Reviews;2016-05
2. Impact of Neoadjuvant Prostate-Specific Antigen Kinetics on Biochemical Failure and Prostate Cancer Mortality: Results From a Prospective Patient Database;International Journal of Radiation Oncology*Biology*Physics;2013-02
3. When to treat prostate cancer patients based on their PSA dynamics;IIE Transactions on Healthcare Systems Engineering;2012-01
4. Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy;Annals of Oncology;2010-04
5. Failure to Achieve a PSA Level ≤1 ng/mL After Neoadjuvant LHRHa Therapy Predicts for Lower Biochemical Control Rate and Overall Survival in Localized Prostate Cancer Treated With Radiotherapy;International Journal of Radiation Oncology*Biology*Physics;2007-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3